{"product_id":"uscap-challenges-in-hematopathology-2022","title":"USCAP Challenges in Hematopathology 2022","description":"\u003cspan style=\"font-size: 14.4px;\"\u003eUSCAP Challenges in Hematopathology 2022 Distinguishing between reactive and neoplastic proliferations in blood, bone marrow, lymph nodes, spleen and extra-nodal hematopoietic tissues, as well as accurately classifying neoplasms once they are identified, are essential for appropriate patient care. Pathologists struggle with differentiating reactive from neoplastic conditions in these organs, as well as in properly classifying hematopoietic neoplasms once they are diagnosed.\u003c\/span\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003e\u003cspan style=\"font-size: 14.4px;\"\u003e This highly respected expert faculty will provide a unique mentoring experience and will cover diagnostic criteria for new entities in the 2016 WHO Classification of Hematopoietic and Lymphoid Neoplasms and provide useful morphologic clues and ancillary techniques to help you distinguish neoplastic and reactive conditions.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n \r\n\u003cdiv class=\"single-main-content\"\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003e\r\n\u003ch3\u003e\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003c\/h3\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp style=\"padding-left: 40px;\"\u003ePracticing academic and community pathologists, and pathologists-in-training\u003c\/p\u003e\r\n\r\n\u003cul\u003e\r\n \t\u003cli\u003e\r\n\u003ch3\u003e\u003cstrong\u003eLearning Objectives\u003c\/strong\u003e\u003c\/h3\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nUpon completion of this educational activity, learners will be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003eBecome familiar with new and rare disease entities involving blood and hematopoietic tissues\u003c\/li\u003e\r\n \t\u003cli\u003eUnderstand the changes caused by reactive and specific infectious agents in hematopoietic tissues\u003c\/li\u003e\r\n \t\u003cli\u003eUnderstand the spectrum of Hodgkin lymphoma and its mimics\u003c\/li\u003e\r\n \t\u003cli\u003eIncorporate the clues and ancillary techniques to differentiate neoplastic from reactive proliferations in blood, bone marrow, lymph nodes, spleen and extranodal hematopoietic tissues\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eProgram : \u003c\/strong\u003e\r\n\r\nItems Included in the Purchase of this Course\r\n\u003cul\u003e\r\n \t\u003cli\u003eBenign and Neoplastic Disorders Initially Encountered on Blood Smears – M. Kathryn Foucar, MD\u003c\/li\u003e\r\n \t\u003cli\u003eMyeloid and Lymphoid Neoplasms and Lookalikes in Bone Marrow – M. Kathryn Foucar, MD\u003c\/li\u003e\r\n \t\u003cli\u003eClassic Hodgkin Lymphoma and Nodular Lymphocyte Predominant Hodgkin Lymphoma and Challenges with Diagnosis and Overlapping Entities – Rebecca L. King, MD\u003c\/li\u003e\r\n \t\u003cli\u003eChallenges With EBV-Related B Cell Lineage Lymphomas\/Lymphoproliferations and Their Classification – Rebecca L. King, MD\u003c\/li\u003e\r\n \t\u003cli\u003eSplenic Tumors and Tumor-Like Proliferations – Daniel A. Arber, MD\u003c\/li\u003e\r\n \t\u003cli\u003eMixed Bag of Hematologic Neoplasms (Examples of New and Novel Entities) – Daniel A. Arber, MD\u003c\/li\u003e\r\n \t\u003cli\u003eSubtle Reactive and Infectious Lymphoid Proliferations – Girish Venkataraman, MD, MBBS Add to Cart\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnosing Castleman and Castleman-Like Lymphoid Proliferations – Girish Venkataraman, MD, MBBS\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eOriginal release date: \u003cspan style=\"color: #ff0000;\"\u003eMay 24, 2022\u003c\/span\u003e\u003c\/strong\u003e\r\n\r\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954602545250,"sku":"MED-AMB06854","price":75.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/USCAP-Challenges-in-Hematopathology-2022.jpg?v=1779380465","url":"https:\/\/meducourse.com\/products\/uscap-challenges-in-hematopathology-2022","provider":"Meducourse","version":"1.0","type":"link"}